Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Nov;21(8):781-3.
doi: 10.1097/00003226-200211000-00010.

Treatment of recurrent corneal erosions using autologous serum

Jose Manuel Benítez del Castillo  1 , Jose Maria Martínez de la Casa, Ricardo Cuiña Sardiña, Rosalia Méndez Fernández, Julian García Feijoo, Alfredo Castillo Gómez, Maria Matilla Rodero, Julian García Sánchez
Affiliations

Treatment of recurrent corneal erosions using autologous serum

Jose Manuel Benítez del Castillo et al. Cornea. 2002 Nov.

Abstract

Purpose: To study the effect of autologous serum in the treatment of recurrent corneal erosions.

Methods: Eleven eyes of 11 consecutive patients with acute macroform corneal erosions who had suffered several relapses despite receiving different types of treatment were analyzed from November 2000 to February 2002. All patients were treated with autologous serum for 3 months.

Results: Mean follow-up time was 9.4 +/- 3.7 months (range, 4-16). No side effects were noted in any of the treated patients. Treatments prior to the use of autologous serum had failed to avoid recurrences in all the patients, with the mean recurrence rate being 2.2 recurrences per month of follow-up. After the onset of serum treatment, only a single recurrence was recorded in three of the patients (0.028 recurrences per month of follow-up).

Conclusion: The use of autologous serum for the treatment of patients with recurrent corneal erosion is effective and safe in reducing the number of recurrences experienced by patients.

PubMed Disclaimer